|
Apr 9
|
Notice to Annual General Meeting in AlzeCure Pharma AB
|
|
Apr 7
|
New Data Bolstering the Anti-inflammatory Effect of NeuroRestore ACD856 Presented at Alzheimer's Conference
|
|
Feb 24
|
New Article Showing the Unique Mechanism of Action Behind Alzstatin as an Alzheimer's Treatment
|
|
Feb 17
|
AlzeCure Receives EU Grant for Phase 2 Clinical Trial of NeuroRestore ACD856 for Alzheimer's Disease
|
|
Jan 21
|
AlzeCure Receives Abstract Acceptance at Alzheimer’s Congress AD/PD 2025 on NeuroRestore ACD856
|